As of 2025-05-17, the Intrinsic Value of Orphazyme A/S (ORPHA.CO) is -1,427.00 DKK. This ORPHA.CO valuation is based on the model Peter Lynch Fair Value. With the current market price of 915.00 DKK, the upside of Orphazyme A/S is -255.96%.
Based on its market price of 915.00 DKK and our intrinsic valuation, Orphazyme A/S (ORPHA.CO) is overvalued by 255.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1,427.00 - -1,427.00 | -1,427.00 | -255.96% |
| P/E | (2,277.49) - (2,580.02) | (2,368.82) | -358.9% |
| DDM - Stable | (1,890.71) - (5,819.19) | (3,854.95) | -521.3% |
| DDM - Multi | (3,782.01) - (9,372.46) | (5,425.75) | -693.0% |
| Market Cap (mil) | 36.60 |
| Beta | -0.47 |
| Outstanding shares (mil) | 0.04 |
| Enterprise Value (mil) | 22.63 |
| Market risk premium | 5.10% |
| Cost of Equity | 11.49% |
| Cost of Debt | 5.00% |
| WACC | 8.19% |